Data Sets
Business deals in the health and wellness sector are thriving as companies work to broaden their offerings, embrace innovation, and maintain an edge in a market shaped by shifting consumer priorities. Mergers and acquisitions have emerged as a central strategy, with global conglomerates and category leaders acquiring emerging and niche wellness brands to access new demographics and align with high-growth trends such as functional nutrition, mental health, fitness tech, and holistic self-care. Strategic partnerships – whether between wellness brands and healthcare providers, fitness platforms, or high-profile athletes – are also becoming more common, leveraging trusted voices and communities to boost engagement and customer loyalty.
At the same time, private equity and venture capital firms are increasingly targeting high-potential health and wellness startups, drawn to their scalable models and disruptive approaches to preventative health, longevity, and personalized care. Cross-industry collaborations, such as alliances between wellness companies and technology innovators, are also accelerating breakthroughs in areas like wearable health monitoring, telehealth integration, and data-driven wellness programs. These deals underscore the sector’s rapid evolution and its drive to meet growing demand for solutions that blend physical, mental, and digital well-being.
With this backdrop, here is a tracker of the most recent mergers, acquisitions, and investments in the health, wellness, and fitness space …
WHOOP has raised $575 million in a Series G round led by Collaborative Fund, valuing the company at $10.1 billion and positioning it to expand its global personalized health platform. The round included major institutional investors such as Qatar Investment Authority and Mubadala, alongside strategic partners like Abbott and high-profile athletes including Cristiano Ronaldo and LeBron James.
The company plans to use the funding to accelerate international expansion across Europe, the Middle East, Latin America, and Asia, while continuing to invest in AI-driven health insights and platform development. WHOOP now has more than 2.5 million members globally and surpassed a $1.1 billion revenue run rate in 2025.
“Our raise brings together the world’s most sophisticated investors behind the mission to unlock human performance and healthspan,” said founder and CEO Will Ahmed. The funding underscores growing investor confidence in preventative, data-driven health platforms as AI and continuous biometric tracking reshape the future of healthcare.
UK-based biotech company Sequential has raised $3.5 million in funding, co-led by Sparkfood and Corundum Systems Biology, bringing total funding to $7.5 million. Sequential develops genomic testing using non-invasive clinical samples to analyze how ingredients impact skin health. Its platform combines microbial and molecular data to generate insights for personal care and biotech applications.
The funding will support the development of an AI-powered discovery engine built on its dataset of over 50,000 samples, enabling the prediction and development of next-generation skincare ingredients and bioactive compounds.
Care Ventures Group (CVG) has made a strategic investment in REN Health Sdn Bhd to support the development of an AI-enabled women’s wellness platform. Financial terms of the investment were not disclosed. REN develops herbal-based solutions targeting female health concerns such as hormonal balance, menstrual support, and postpartum recovery. With the new backing, the company plans to expand beyond product distribution into a technology-driven model focused on predictive health insights and personalized wellness solutions.
The funding will support the development of AI-powered recommendation engines, predictive subscription systems aligned with hormonal cycles, and enhanced data analytics capabilities. REN will also leverage CVG’s digital ecosystem to accelerate distribution and scale its women’s health offerings.
Unilever Ventures has taken a minority stake in Novos, a science-driven longevity biotech company founded in 2019 by CEO Chris Mirabile. Financial terms were not disclosed. The New York–based company develops nutraceutical products aimed at targeting the biological causes of aging. Its flagship product, Novos Core, launched in 2021 and is designed to address multiple “hallmarks of aging” using a formulation of natural molecules. The investment will support further clinical research and expansion of Novos’ longevity-focused product portfolio.
Seqens has agreed to sell its Botanical Actives and In Vitro Diagnostics (IVD) activities in Limoges, France, to Solabia, a specialist in natural ingredients for personal care, life sciences, and diagnostics. Financial terms were not disclosed. The transaction aligns with Seqens’ strategy to focus on its core Pharmaceutical Solutions and selected Specialty Ingredients businesses. Solabia will integrate the Limoges operations to expand its capabilities in botanical actives and diagnostics.
Seqens said the move ensures a long-term industrial future for the site while allowing the group to concentrate resources on its strategic priorities, including biotech-based ingredients and performance solutions for personal care markets.
Mumbai-based pharmaceutical company USV will acquire a 79% stake in nutraceutical brand Wellbeing Nutrition, marking its entry into India’s fast-growing direct-to-consumer wellness market. Founded in 2019, Wellbeing Nutrition offers vitamins, protein, collagen, omega-3, and other supplements sold through its website, online marketplaces, and more than 6,000 retail outlets, with international presence in the US, UK, and UAE. The acquisition reflects USV’s strategy to expand beyond prescription medicines into preventive and lifestyle-focused healthcare.
Everlab has secured $10 million in funding from early-stage healthcare investors to accelerate the growth of its preventive health platform. The company will use the capital to expand its proactive testing and diagnostics services, while enhancing its personalised wellness programmes designed to help individuals detect risks earlier and optimise long-term health outcomes.
The funding supports Everlab’s broader mission to shift healthcare from reactive treatment to data-driven, preventive care.
Robin Health, a Milan-based healthtech startup focused on prevention and digital health management, has raised €2 million in a pre-seed funding round led by Step Fund. The company will use the funding to expand operations and accelerate product development.
Robin Health offers a platform that integrates behavioural, biometric, and clinical data into a user-friendly experience, translating insights into actionable information for healthcare professionals. The solution supports the daily management of obesity and overweight through a preventive, personalized, and data-driven approach. The platform is available on the App Store and Google Play.
British gut health brand Epetōme has raised a multimillion-pound investment round co-led by Active Partners and Redrice Ventures to support international expansion and clinical research. Founded in 2023 by nutritionist and author Emily English, the company focuses on science-backed gut health supplements. The funding will support global scaling and further research into probiotics, prebiotics, and the human microbiome.
Epetōme’s flagship product, Synbiotic Duo Cap, combines 11 bacterial strains delivering 50 billion live organisms and has helped the brand rapidly grow in the UK supplements market.
Berlin-based Circle Health has raised €9 million in seed equity and debt financing led by Atlantic.vc, with participation from CRB Health Tech, Calm/Storm Ventures, and Kfund. Founded by Peter Malmqvist and Jannik Tiedemann, the company is building Circle OS, an AI-powered preventive health platform that combines in-person diagnostics with digital tools and wearable data to deliver personalised programmes focused on metabolic, hormonal, and gut health.
Since launching its Berlin clinic in 2023, Circle Health has treated several thousand patients. The new funding will support further product development and expansion of its hybrid clinic model to cities including Munich, Hamburg, and Düsseldorf.
Aire Ancient Baths has partnered with strategic investor Khemia, which has taken a minority stake in the company to support international expansion. Financial details were not disclosed. Founded in 2001 in Seville, Aire Ancient Baths operates wellness facilities inspired by Greek, Roman, and Ottoman bathing traditions. The company currently has 10 locations across Europe and North America.
The new investment will fund the gradual opening of additional facilities in selected global markets as Aire accelerates its growth strategy.
Mira Kapoor’s wellness startup, Dhun Wellness, has secured $4 million in funding from Indian family offices including SRF Ltd (Kama Group) and Havells India (QRG Investment & Holdings), as well as angel investors such as Arushi Aayush Agrawal and Ash Lilani of Saama Capital.
Founded in 2023, Dhun blends traditional Indian healing practices with modern longevity science to offer personalized wellness programs for urban consumers. The funding will fuel expansion into Delhi, Pune, Hyderabad, Bengaluru, and Ahmedabad, and enhance Dhun’s clinical and preventive health offerings.
“Our vision is to create accessible wellness ecosystems rooted in science and tradition,” said founder Mira Kapoor. The company reports a 15% month-over-month rise in demand, reflecting India’s growing appetite for integrated, city-based wellness solutions.
Toronto-based healthcare technology company Science&Humans has closed a $10 million oversubscribed Series A round, combining equity and debt financing. The round was led by Pender Ventures, with participation from WELL Health Technologies, Michele Romanow, CIBC Innovation Banking, and U.S. healthcare investors.
Founded by Hira Siddiqui and Aftab Pashaw, Science&Humans offers a clinical and consumer platform focused on hormone health, a historically overlooked pillar of wellness that affects everything from mood and sleep to fertility and aging. The new funding will support the company’s efforts to scale proactive, evidence-based care models for hormone-related conditions across all life stages.
“Hormone health is moving into the mainstream in much the same way mental health did a decade ago,” said investor Michele Romanow.
French healthtech startup Lucis has closed an $8.5 million seed round to expand its preventive health testing platform across Europe. The round was led by General Catalyst, with participation from Y Combinator, Kima Ventures, Motier Ventures, Circle.Co, and North South Ventures.
Founded by Maxime Berthelot, Baptiste Debever, and Max Guerois, Lucis helps individuals track 180+ biomarkers, spanning cardiometabolic health, hormones, inflammation, and more, through recurring lab tests and an AI-powered dashboard. The platform delivers personalized action plans focused on five areas: nutrition, supplements, activity, sleep, and mental health.
The new funding will support Lucis’ expansion in France, the UK, Ireland, and Portugal, while growing its lab and clinical networks and advancing its AI capabilities. “Our mission is to give people clarity and control over their health, long before symptoms appear,” said CEO Maxime Berthelot.
Biologica, a new women’s wellness brand founded by Liz Zwillinger and Allbirds co-founder Joey Zwillinger, has officially launched alongside a $7 million seed round led by Addition. The brand introduces a line of science-backed, stage-specific daily essentials tailored to support women through the reproductive years, perimenopause, and postmenopause.
Investors include Hawktail (Michael Polansky), Greycroft (Katherine Power), True Beauty Ventures, Good Friends (founders of Warby Parker, Harry’s, and Flamingo), Gabrielle Bernstein, and Katherine Schwarzenegger Pratt.
Born from Liz Zwillinger’s personal experience navigating hormonal health, Biologica aims to simplify women’s wellness with targeted nutrition and one delicious daily routine. “Women’s bodies change but most products don’t,” said Zwillinger. “Biologica is here to change that.”
UK-based healthtech platform MANUAL has acquired FORMEL SKIN, Germany’s leading digital dermatology provider, in a move that signals the group’s expansion from skin health to whole-body care. The combined company aims to deliver Europe’s most advanced medical weight-loss program and build a category-defining unified health platform.
Founded in 2019, FORMEL SKIN has delivered over 2 million treatments through a digital model that blends clinical expertise with personalized care. The Berlin-based company has become a trusted leader in digital dermatology, known for its strong treatment outcomes and academic partnerships.
“This is the most important milestone in FORMEL SKIN’s journey,” said CEO Florian Semler, who will continue in his role. “Together with MANUAL, we’re ready to expand into new verticals and markets.”
Function Health, the AI-driven lab testing and health data platform, has raised $298 million in a Series B round led by Redpoint Ventures, bringing its valuation to $2.5 billion. Investors in the round include a16z, Aglaé Ventures, Battery Ventures, NFDG, and notable angels such as Allen Crabbe, Blake Griffin, and Anthony Wood.
The raise brings Function’s total funding to $350 million as it accelerates its mission to make personalized health data actionable for everyone. Founded by Jonathan Swerdlin, Function helps users track and understand their health through regular lab testing, consolidated health records, and AI-powered insights. The company also unveiled its Medical Intelligence Lab, where it’s developing a generative AI model trained by physicians to deliver tailored health guidance across lab results, doctor notes, and scan data.
“It’s not good enough to live in a world with AI and not apply it to your health,” said Swerdlin. “We’re here to help people manage their biology with the best tech available.”
Wellness tech startup Unlimitr has raised $1.1 million in seed funding from a group of Texas-based investors, valuing the company at $7 million. The funds will fuel the development of AI and analytics capabilities, expand global partnerships, and support the launch of a coach training and community engagement program. Formerly known as Health Click Away, Unlimitr was co-founded in 2020 by Ruchika Gupta and Gaurav Agarwal. Operating in over 40 countries, the platform connects 98,000 users with 5,000+ certified wellness professionals and delivers personalized health journeys powered by AI and human insight.
“What started as a personal need has evolved into a global ecosystem backed by AI, science, and compassion,” said Gupta, Unlimitr’s co-founder and CEO. “With this investment, we’re set to make Unlimitr the go-to wellness destination.”
TRIP, the world’s leading calming drinks brand, has raised $40 million in a funding round backed by celebrities including Joe Jonas, Alessandra Ambrosio, Paul Wesley, Ashley Graham, and consumer growth fund Coefficient Capital. The investment supports TRIP’s rapid U.S. expansion as the brand is projected to hit $100 million in revenue this year and $200 million by 2026. With products now available in 10,000 U.S. retail doors, including Target, Whole Foods, CVS, and Soho House, TRIP is tapping into surging demand for better-for-you beverages that support stress management and alcohol-free lifestyles.
“We created TRIP to make daily calm accessible to everyone, everywhere,” said Olivia Ferdi, CEO and founder. “This round will help us deliver a billion moments of calm while continuing to scale our community-led innovation.”
Functional wellness brand Plant People has raised an undisclosed Series A round led by global private equity firm Manna Tree, with continued backing from early investor Unilever Ventures. The deal gives Manna Tree a significant minority stake as the brand prepares to scale its clean-label supplement line and expand distribution.
Founded in 2018 by Hudson Davis-Ross and Gabe Kennedy, Plant People creates science-backed Wonder gummies formulated with plant-based ingredients to support sleep, stress, focus, hydration, beauty, and weight management. The brand has become a category leader at Whole Foods, Sprouts, and Erewhon, with strong DTC traction and top-rated reviews on Amazon.
“We’ve built a profitable, purpose-led brand with minimal capital – and now, with Manna Tree’s partnership, we’re ready to grow faster and smarter,” said CEO Hudson Davis-Ross.
Premium supplements brand Cymbiotika has raised $25 million in fresh funding, bringing on high-profile investors from the sports and music industries as it scales its clinically tested, high-absorption formulations. Known for its liquid and liposomal gel formats, Cymbiotika has sold over 100 million single-serve packets to date and is now expanding distribution through a new deal with Target.
The San Diego-based brand offers a wide range of bioavailable supplements – from Irish sea moss to magnesium complex – designed to support energy, cognition, beauty, and daily performance. The funding positions Cymbiotika to surpass $150 million in sales in 2025.
Sandbar, a wearable tech startup founded by ex-Meta engineers, has raised $13 million to launch Stream, a minimalist, voice-controlled smart ring designed to make human-computer interaction feel as natural as thought. The round was led by True Ventures, with participation from Upfront Ventures and Betaworks.
Worn on the dominant index finger, Stream transcribes whispers with high accuracy, offers gesture-based controls, and syncs with a companion iOS app. A Pro tier unlocks deeper features for $10/month, while preorders start at $249. “We’re building a bridge between thought and action,” said CEO Mina Fahmi. “Stream listens only when you want it to and responds like a trusted companion.”
Midlands-founded health-tech startup Rem3dy Health has raised £1.4 million to fuel international growth and advance R&D for its flagship personalised nutrition brand, Nourished. The round was led by Amsterdam-based Borski Fund (£900K) and Future Planet Capital Regional (£500K). Founded by Melissa Snover, Rem3dy Health uses patented 3D printing technology to create custom, stackable nutrition gummies tailored to individual health needs, positioning Nourished at the forefront of preventative wellness.
“This is about more than capital, it’s a signal that regionally based, high-growth companies can attract global backing when given the right platform,” said Snover.
Recess, the pioneer in relaxation beverages, has closed a $30 million Series B round led by CAVU Consumer Partners, with participation from Rocana, Midnight Ventures, Torch Capital, Doehler Ventures, KAS Venture Partners, Vanquish, and Craig Kallman. The funding will support team growth, retail expansion, and increased marketing as Recess positions itself as the go-to brand for functional calm.
Alongside the raise, Recess appointed Kyle Thomas, former Global Chief Commercial Officer at Nutrabolt (C4 Energy, Bloom), as President and Co-CEO, joining founder Ben Witte to lead the company’s next growth phase. Recess, known for its Mood and Zero Proof beverage lines, is redefining what modern relaxation looks like for overstimulated consumers. Backer CAVU, whose recent success includes poppi’s $1.95B Pepsi acquisition, sees Recess as a defining brand in the emerging $25B+ counter-stimulation market.
“Recess isn’t about powering through the day, it’s about being more mindful within it,” said Jared Jacobs, Partner at CAVU. “We believe Recess is building the next household name in mental wellness.”
Sweatpals, a platform reimagining social connection through wellness and fitness, has raised $12 million in seed funding to expand its fitness-focused social network. The round was led by Patron and a16z speedrun, with participation from HartBeat Ventures, Max Mullen (Instacart), WndrCo, Pear, Antler, and Deb Liu. This brings the company’s total funding to $17.2 million.
Founded in 2022 by Salar Shahini and Mandi Zhou, Sweatpals helps users discover, join, and host local fitness events, transforming workouts into community-driven experiences. The platform also offers tools that let fitness hosts monetize their events, boosting revenue by up to 30% while fostering deeper connections.
“Sweatpals uses workouts to build true communities,” said Shahini. “We’re creating infrastructure for a generation that wants real-life connection outside of nightlife, through movement and shared purpose.”
French startup Kotcha, co-founded by marathon world record holder Eliud Kipchoge, has raised €3.5 million in a round led by Racine2, with backing from True Global, Motier Ventures, and others. The funds will support European expansion, team growth, and further development of Kotcha’s AI engine.
Unlike standard apps with fixed training plans, Kotcha offers dynamic, daily-updated schedules and real-time support through four AI personas, coach, trainer, nutritionist, and analyst, trained on Kipchoge’s own team. The app provides run briefings, debriefs, and 24/7 answers to training, nutrition, and recovery questions.
“Our mission is to bring the team experience to every runner,” said CEO Ben Dupont.
Women’s wellness brand Unfabled has raised $1.7 million in new funding to support its rapid expansion across the UK, bringing its total capital raised to $3.9 million. The round was led by London-based Arāya Ventures, backed by British Business Investments, with participation from previous investors including Morgan Stanley, Exceptional Ventures, and Atomico Angels. Founded in 2021 by Forbes 30 Under 30 honouree Hannah Samano, Unfabled offers supplements targeting bloating, cramps, sleep, stress, and energy, developed through a community-led R&D approach via Unfabled Labs.
The funding coincides with a major retail milestone: Boots is rolling out Unfabled’s range to 737 stores nationwide, a 1,000% increase from its initial 50-store launch in late 2024. As a graduate of the Boots Ignite accelerator, Unfabled is one of the program’s first wellness brands to achieve national scale.
With fresh capital and retail momentum, Unfabled is doubling down on its mission to redefine women’s health with science-backed, consumer-driven innovation.
Belgian wellness brand Insentials has secured its first outside investment, welcoming French venture capital fund Eutopia and FG Bros, the Frère-Gallienne family office, as minority stakeholders. Previously self-funded, Insentials is known for its personalized, science-backed supplements tailored to women’s health. The funding will enable the brand to scale operations, expand across Europe, and deepen its commitment to personalized wellness solutions.
“This marks a new chapter for Insentials as we continue our mission to make health truly personal,” said founder and CEO Lynn De Proft.
Oura Health Oy, the Finnish company behind the popular Oura Ring, is raising $875 million in a Series E round that values the company at approximately $10.9 billion, more than double its $5 billion valuation from its Series D in December 2024, according to Bloomberg. The round could exceed $900 million and is expected to close by the end of the month.
Oura reportedly plans to use the capital to scale production, invest in product development, and drive international expansion. The company has sold 5.5 million rings to date, up from 2.5 million in mid-2024, and is on track to generate over $1 billion in revenue this year, doubling its 2024 total. Sales are forecast to surpass $1.5 billion in 2026. The raise comes alongside a $250 million credit line secured from JPMorgan, Goldman Sachs, Citigroup, and Barclays, further positioning Oura to scale as a global leader in wearable health tech.
Digital maternal health startup Lōvu Health has raised $8 million in Series A funding to enhance its AI capabilities and expand its integrated care platform. The round was led by SJF Ventures, with participation from Rogue Women’s Fund, Symphonic Capital, Emmeline Ventures, Majella Ventures, and others, bringing the company’s total funding to $14 million.
Based in Cupertino, Lōvu supports mothers and babies from conception through two years postpartum. Its platform pairs patients with pregnancy navigators, connects vitals-tracking devices to OBs, and offers mental health tools, personalized guidance, and access to third-party specialists like doulas, lactation consultants, and physical therapists.
“SJF has had a long-standing interest in maternal health, and Lōvu stood out as a win-win-win for providers, health plans, and mothers,” said Perry Clarkson, Partner at SJF Ventures.
Birmingham-based health and wellness company resbiotic has raised $14.5 million in total funding, including an $8 million Series A round led by Sororibus Capital and Biostack Ventures. Founded by Dr. C. Vivek Lal, resbiotic is known for its science-backed Gut-X Axis platform, which links gut health to whole-body outcomes. The company’s flagship product, resB Lung Support, is the first clinically tested probiotic targeting the gut–lung axis for respiratory health.
The new funding will support expansion into metabolic, women’s, and bone health, as well as retail and e-commerce scale-up and growth of its B2B formulations business.
Lisbon-based Nutrium has secured $12 million in Series A funding to expand its all-in-one corporate nutrition solution. The round was led by Vesalius Biocapital, with participation from Lince Capital, Indico Capital Partners, and Beta Capital. Nutrium connects millions of patients to a global network of over 350,000 registered dietitians across 90+ countries, offering personalized meal planning, chronic disease management, and preventive care. The funding comes as employers seek sustainable, non-pharmaceutical strategies to curb rising healthcare costs amid increasing obesity rates and demand for GLP-1 medications.
“Nutrition has become a business priority,” said CEO and Co-founder André Santos. “This funding allows us to scale our impact and deliver measurable outcomes for companies and their people worldwide.”
Longevity-focused health tech company Fountain Life has secured $18 million in Series B funding to accelerate the expansion of its preventative care centers and early detection services. The round was led by EOS Ventures and included participation from existing board members, bringing the company’s total funding to $108 million. Co-founded by Dr. William Kapp, Dr. Peter Diamandis, and Tony Robbins, Fountain Life uses advanced diagnostics, including blood tests and full-body scans, to monitor over 100 biomarkers and detect chronic conditions at their earliest, often asymptomatic stages.
Fountain Life offers annual membership plans starting at $10,500, with quarterly testing and results delivered through an AI-powered app. The company also aims to improve affordability by training external medical providers in its preventative care model. The new capital will support the opening of additional centers in Houston, Los Angeles, and Miami, adding to its existing locations in Naples, Westchester, Orlando, and Dallas.
“Our mission is to shift healthcare from reactive to proactive,” said CEO Dr. William Kapp. “With this funding, we’re expanding access to cutting-edge diagnostics and personalized health optimization.”
THG Group, owner of MyProtein, has agreed to sell its Claremont Ingredients business to international flavour specialist Nactarome for £103 million. Claremont, a UK-based flavor manufacturing and development lab serving sports nutrition, bakery, and beverage sectors, joined THG Nutrition in 2020 to accelerate MyProtein’s global licensing and new product development efforts. THG said the deal delivers a “significant return” through cash generation and sale proceeds, while preserving a long-term supply relationship with Nactarome.
“Claremont has been a huge success, building MyProtein’s global licensing franchise from a standing start,” said THG CEO Matthew Moulding. “The level of interest reflects the quality of the business and the value embedded across THG’s portfolio.” Nactarome, majority-owned by TA Associates, operates in nine European countries and said the deal marks its entry into sports nutrition, complementing its flavour and ingredient expertise.
U.K.-based Ditto Daily has raised £1.35 million ($1.72 million) in pre-seed funding to expand its science-backed Cycle Supplement for menstrual symptoms. Led by Eka Ventures with participation from Jean-Baptiste Wautier, the round will fund clinical research, product innovation, and channel growth. Co-developed with Dr. Anita Mitra, the supplement uses “beadlet-in-oil” nutrient delivery for enhanced absorption and has seen strong uptake since its launch four months ago. A recent clinical trial showed 88% of participants reported reduced symptom severity.
“For too long, there has been a huge disconnect between what science understands and the solutions available,” said founder and nutrition scientist Alice van der Schoot. “This funding allows us to accelerate our research and deliver more evidence-based solutions to the billions of women who need them.”
UK-based fertility wellness startup The OVA Co has raised over $1 million in a pre-seed round led by ERA VC, with participation from Ventures Together, Syndicate Room, and a roster of prominent angel investors. The round will support the brand’s expansion into Ireland, retail growth, and deeper retail partnerships across 800+ locations including Boots and Sainsbury’s. Founded just seven months ago by former Net-A-Porter executives Danielle Fox-Thomas and Kat Lestage, The OVA Co offers fertility supplements for both egg and sperm health, combining clinical science with consumer-friendly design. The brand is part of Google’s high-growth business program and aims to bring empathy and transparency to a historically clinical category.
“The fertility aisle hasn’t caught up with how people are actually trying to conceive,” said Lestage. “We’re building a smarter, more inclusive approach to fertility support.”
Othership, the immersive wellness brand blending sauna, cold plunge, and breathwork, has closed an $8.5 million SAFE note to fuel its New York City expansion. The round includes strategic backing from Rocana Ventures, Vine Ventures, Winklevoss Capital, Blake Mycoskie, Kerry Washington, NBA star Bradley Beal, and Devon Lévesque. CEO Robbie Bent clarified that reports citing an $11.3 million raise were inaccurate.
Following the success of its Flatiron location, Othership will open a new Williamsburg club this fall, with a 13,000-square-foot flagship to follow. The upcoming space will double the size of its current offering and introduce a “bathing wing” with steam rooms, warm pools, 1:1 emotional therapies, and expanded class programming.
“We’re evolving to meet member needs,” said Bent. “There’s a natural opportunity to bring emotional wellness into the traditional bathhouse model.”
Arketa, an AI-driven platform for boutique fitness and wellness studios, has raised $15 million in Series A funding led by Inspired Capital, with participation from First Round, Y Combinator, and Amity. The funding will fuel product innovation and market expansion as the boutique fitness industry, projected to reach $80 billion by 2029, continues to surge.
Founded to modernize operations for fitness entrepreneurs, Arketa equips studios with enterprise-grade tools including automated customer support, intelligent booking and pricing, and built-in marketing automation. The platform is designed to help small and mid-sized businesses scale while offering personalized, tech-enabled wellness experiences.
“As a certified yoga instructor, I saw how outdated systems held back studios,” said Co-founder and CEO Rachel Lea Fishman. “Arketa gives them the tools they need to grow, thrive, and create stronger community connections.” Inspired Capital’s Chris Brown added, “Arketa represents the future of vertical SaaS, platforms that not only solve core needs like booking and payments, but evolve into the operating system for entire industries.”